Roberto Cuca - 23 Feb 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: COO and CFO
Signature: /s/ Megan Smeykal, Attorney-in-fact
Issuer symbol: TELA
Transactions as of: 23 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 25 Feb 2022, 16:09:20 UTC
Previous filing: 03 Dec 2021
Next filing: 07 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock	Award	$0	+15,500	+353%	$0.000000	19,892	23 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TELA	Stock Option (Right to Buy)	Award	$0	+26,600		$0.000000	26,600	23 Feb 2022	Common Stock	26,600	$11.75	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2	The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.